Pre-earnings options volume in Sellas Life Sciences is 2.1x normal with calls leading puts :. Implied volatility suggests the market is anticipating a move near 12.0%, or 0c, after results are released. Median move over the past eight quarters is 7.0%.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SLS:
- SELLAS Life Sciences Announces Executive Shake-up and Reorganization Strategy
- Sellas Life announces departure of CCO Francomano, General Counsel Wood
- SELLAS Announces Executive Leadership Reorganization and Prioritization of Commercialization Partnerships
- Largest borrow rate increases among liquid names
- SELLAS Life Sciences Delivers Oral Presentation of SLS009 Phase 1 Data for Acute Myeloid Leukemia Patients at 2024 European School of Haematology (ESH) Conference
